| Literature DB >> 26401931 |
Xiao-Fang Zhang1, Yan-Feng Zhao2, Shun-Wei Zhu3, Wei-Jie Huang3, Yan Luo3, Qing-Ying Chen3, Li-Jun Ge4, Run-Sheng Li2, Jian-Fei Wang4, Mu Sun3, Zhi-Cheng Xiao1,5, Guo-Huang Fan2,6,7,8.
Abstract
Truncation of tau protein is considered an early event in Alzheimer's disease (AD) and is believed to play a major pathogenic role in sporadic AD. However, causative factors that trigger tau truncation in AD remain poorly understood. In the present study, we demonstrate that CXCL1 (C-X-C motif ligand 1), a specific ligand for the chemokine receptor CXCR2, induced cleavage of tau at ASP421 in a caspase-3-dependent manner in long-term but not short-term cultured neurons. The cleaved tau formed varicosities or bead-like structures along the neurites, an abnormal distribution of tau induced by CXCL1 that has not been observed previously. CXCL1-induced activation of GSK3β and the subsequent phosphorylation of tau preceded and were required for caspase-3 activation and tau cleavage. Moreover, intrahippocampal microinjection of lentiviral CXCL1 induced tau cleavage in hippocampal neurons in aged (15-18 months of age) but not adult mice (5-10 months of age). Our data highlight a new role of CXCR2 in tau cleavage and suggest that targeting CXCR2 may offer therapeutic benefits to patients with AD and potentially other tauopathies.Entities:
Keywords: CXCL1; CXCR2; Caspase-3; hippocampal neurons; tau cleavage
Mesh:
Substances:
Year: 2015 PMID: 26401931 DOI: 10.3233/JAD-150041
Source DB: PubMed Journal: J Alzheimers Dis ISSN: 1387-2877 Impact factor: 4.472